HK1082509A1 - Method for isolating an intestinal cholesterol binding protein - Google Patents

Method for isolating an intestinal cholesterol binding protein

Info

Publication number
HK1082509A1
HK1082509A1 HK06103145A HK06103145A HK1082509A1 HK 1082509 A1 HK1082509 A1 HK 1082509A1 HK 06103145 A HK06103145 A HK 06103145A HK 06103145 A HK06103145 A HK 06103145A HK 1082509 A1 HK1082509 A1 HK 1082509A1
Authority
HK
Hong Kong
Prior art keywords
isolating
binding protein
intestinal cholesterol
cholesterol binding
intestinal
Prior art date
Application number
HK06103145A
Other languages
English (en)
Inventor
Werner Kramer
Wendelin Frick
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of HK1082509A1 publication Critical patent/HK1082509A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK06103145A 2002-08-06 2006-03-13 Method for isolating an intestinal cholesterol binding protein HK1082509A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02017504 2002-08-06
PCT/EP2003/008290 WO2004014947A1 (en) 2002-08-06 2003-07-28 Method for isolating an intestinal cholesterol binding protein

Publications (1)

Publication Number Publication Date
HK1082509A1 true HK1082509A1 (en) 2006-06-09

Family

ID=31502689

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06103145A HK1082509A1 (en) 2002-08-06 2006-03-13 Method for isolating an intestinal cholesterol binding protein

Country Status (17)

Country Link
US (2) US7435727B2 (xx)
EP (1) EP1529061B1 (xx)
JP (1) JP4575772B2 (xx)
KR (1) KR101095288B1 (xx)
CN (1) CN1330667C (xx)
AT (1) ATE386053T1 (xx)
AU (1) AU2003253341C1 (xx)
BR (1) BR0313217A (xx)
CA (1) CA2493487C (xx)
DE (1) DE60319093T2 (xx)
HK (1) HK1082509A1 (xx)
IL (2) IL166492A (xx)
MX (1) MXPA05001264A (xx)
NO (2) NO333437B1 (xx)
RU (1) RU2345089C2 (xx)
WO (1) WO2004014947A1 (xx)
ZA (1) ZA200500053B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
US7135556B2 (en) 2002-07-19 2006-11-14 Schering Corporation NPC1L1 (NPC3) and methods of use thereof
AU2004303742B2 (en) 2003-12-23 2008-06-19 Astrazeneca Ab Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity
EP1723414A4 (en) 2004-01-16 2008-03-26 Merck & Co Inc NPC1L1 (NPC3) AND METHOD FOR IDENTIFYING ITS LIGANDS
CN101243072A (zh) 2005-06-20 2008-08-13 先灵公司 用作组胺h3拮抗剂的哌啶衍生物
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
WO2007100807A2 (en) 2006-02-24 2007-09-07 Schering Corporation Npc1l1 orthologues
AR060623A1 (es) 2006-04-27 2008-07-02 Astrazeneca Ab Compuestos derivados de 2-azetidinona y un metodo de preparacion
CN1869704B (zh) * 2006-06-14 2010-06-30 厦门大学 快速鉴定与病原菌互作的宿主蛋白的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710469A (en) * 1986-05-02 1987-12-01 Merck & Co., Inc. Novel phosphotyrosyl protein phosphatase
CA2002607C (en) 1988-11-10 2004-01-27 Gordon G. Wong Natural killer stimulatory factor
ES2168091T3 (es) * 1990-05-16 2002-06-01 Genetics Inst Proteinas de induccion osea y cartilaginosa.
US5264372A (en) 1991-03-15 1993-11-23 Amylin Pharmaceuticals, Inc. Receptor-based screening methods for amylin agonists and antagonists
US5518911A (en) 1995-01-06 1996-05-21 Onyx Pharmaceuticals, Inc. Human PAK65
JP3088681B2 (ja) 1997-05-22 2000-09-18 宮城県 形質膜局在シアリダーゼ及びそれをコードするｄｎａ
US6383734B1 (en) 1998-09-30 2002-05-07 Advanced Research And Technology Institute, Inc. Method to determine inhibition of PAK3 activation of Raf-1
JP2000166545A (ja) * 1998-12-07 2000-06-20 Snow Brand Milk Prod Co Ltd 胆汁酸活性化リパーゼ
AU3566200A (en) 1999-04-01 2000-10-23 Astrazeneca Uk Limited Human signal transduction serine/threonine protein kinase
AU4343500A (en) * 1999-04-16 2000-11-02 Schering Corporation Use of azetidinone compounds
DE10042447A1 (de) * 2000-08-29 2002-03-28 Aventis Pharma Gmbh Protein aus dem Darm von Wirbeltieren, welches Cholesterin absorbiert, sowie Verwendung dieses Proteins zur Identifizierung von Inhibitoren des intestinalen Cholesterintransports

Also Published As

Publication number Publication date
CN1330667C (zh) 2007-08-08
DE60319093T2 (de) 2009-02-05
BR0313217A (pt) 2005-06-14
US7435727B2 (en) 2008-10-14
AU2003253341C1 (en) 2009-09-24
US20080167451A1 (en) 2008-07-10
ZA200500053B (en) 2006-07-26
JP4575772B2 (ja) 2010-11-04
NO333437B1 (no) 2013-06-03
IL166492A0 (en) 2006-01-15
CA2493487C (en) 2013-01-22
JP2006512054A (ja) 2006-04-13
US20040126812A1 (en) 2004-07-01
RU2345089C2 (ru) 2009-01-27
US7786103B2 (en) 2010-08-31
AU2003253341A1 (en) 2004-02-25
ATE386053T1 (de) 2008-03-15
RU2005106238A (ru) 2005-08-27
WO2004014947A1 (en) 2004-02-19
DE60319093D1 (de) 2008-03-27
CA2493487A1 (en) 2004-02-19
KR101095288B1 (ko) 2011-12-16
KR20060015443A (ko) 2006-02-17
IL199409A (en) 2010-12-30
EP1529061B1 (en) 2008-02-13
CN1668642A (zh) 2005-09-14
EP1529061A1 (en) 2005-05-11
AU2003253341B2 (en) 2009-04-23
IL166492A (en) 2010-12-30
MXPA05001264A (es) 2005-04-28
NO20051169L (no) 2005-05-02
NO20130115L (no) 2005-05-02

Similar Documents

Publication Publication Date Title
HK1082509A1 (en) Method for isolating an intestinal cholesterol binding protein
CA2545989A1 (en) Method and device for purifying nucleic acids
AU2002210446A1 (en) Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport
HK1083443A1 (en) Thiazolidin-4-ones for inhibiting hyak3 proteins
AU2003294598A8 (en) Method for launching applications
IL175565A0 (en) Gag binding proteins and a method for introducing a gag binding site into a protein
SI2261230T1 (sl) Postopek čiščenja proteinov
EP1642136A4 (en) PROCESS FOR THE ISOLATION OF A PROTEIN
AU2003271946A8 (en) Tool-tip for multimedia files
AU2003287642A1 (en) Process for solubilizing protein
AU2003290735A1 (en) Inhibitors of monoamine uptake
AU2003263756A1 (en) Methods for peptide-protein binding prediction
AU2003296775A8 (en) Novel method for isolating endotoxins
WO2003087051A3 (en) Methods for identifying allosteric sites
HK1080089A1 (zh) 鼠李糖結合蛋白
AU2003304409A8 (en) Evaluating protein signatures
AU2003202168A1 (en) Processes for improving binding capability and biological digestability
EP1808191A4 (en) ADSORBENT FOR LYMPHOCYTE PROLIFERATION INHIBITOR AND PROCESSING METHOD
AU2003208649A1 (en) Method of extracting, isolating and purifying sesame protein
AU2003292063A8 (en) Methods for identifying members of specific binding pairs
AU2003240683A1 (en) Method for creating polynucleotide molecules
EP1739089A4 (en) PROCESS FOR DISINTER SEPARATION
AU2003904069A0 (en) Method for detection of protein binding
AU2003214103A1 (en) Method for identifying specific rna-inhibitors
HK1045785A2 (en) Book-binding method for textbooks